Clinical trial
A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320…
NCT00241137 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00241137 |
|---|---|
| Title | A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg |
| Official title | A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | valsartan |
| Enrollment | 3,790 |
| Start date | Sep 1, 2003 |
| Primary completion | Jan 1, 2005 |
| Completion | Jan 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | Nov 23, 2011 |
| Countries | Germany |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: